|
|
Volumn 25, Issue 19, 2007, Pages
|
|
Questions about the role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
KERATINOCYTE GROWTH FACTOR;
PLACEBO;
CHEMICALLY INDUCED DISORDER;
COLORECTAL TUMOR;
CRYOTHERAPY;
DRUG ADMINISTRATION;
DRUG EFFECT;
HUMAN;
METASTASIS;
METHODOLOGY;
MOUTH MUCOSA;
NOTE;
SKIN;
STATISTICAL ANALYSIS;
STOMATITIS;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
CRYOTHERAPY;
DATA INTERPRETATION, STATISTICAL;
DRUG ADMINISTRATION SCHEDULE;
FIBROBLAST GROWTH FACTOR 7;
FLUOROURACIL;
HUMANS;
MOUTH MUCOSA;
NEOPLASM METASTASIS;
PLACEBOS;
RESEARCH DESIGN;
SKIN;
STOMATITIS;
TREATMENT OUTCOME;
|
|
EID: 34447551612
PISSN: None
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2007.11.6285 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
